Ra Capital Management, L.P. Uro Gen Pharma Ltd. Put Options Transaction History
Ra Capital Management, L.P.
- $4.82 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding URGN
# of Institutions
139Shares Held
37.7MCall Options Held
91.4KPut Options Held
42.1K-
Rtw Investments, LP New York, NY3.83MShares$41.5 Million0.69% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.9 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.7 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$23.3 Million1.7% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$18.9 Million0.04% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $246M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...